3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Polycythemia Vera
2
Myeloproliferative Disorders
2
Lung Neoplasms
2
Tuberous Sclerosis
1
Smoking
1
Renal Insufficiency, Chronic
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Multiple Sclerosis
1
Lymphangioleiomyomatosis
1
Liver Cirrhosis, Biliary
1
Lip Neoplasms
1
Irritable Bowel Syndrome
1
Inflammatory Bowel Diseases
1
Hepatitis
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Gastritis
1
Fibrosis
1
Exocrine Pancreatic Insufficiency
1
Endocrine Gland Neoplasms
1
Dyslipidemias
1
Diabetes Mellitus
1
Cystic Fibrosis
1
Crohn Disease
1
Chronic Pain
1
Chronic Disease
1
Interventions
selpercatinib
2
temsirolimus
1
repotrectinib
1
Valproic Acid
1
Sirolimus
1
Psilocybin
1
Phlebotomy
1
Immunoglobulin G
1
Etoposide
1
Disulfides
1
Cyclophosphamide
1
Cetuximab
1
Biopsy, Large-Core Needle
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endocrine Gland Neoplasms
×
Phlebotomy
×
1 year
×
Clear all
NCT07121998
2025-08-14
PROGRESS-TMZ
Uppsala University
Recruiting
94 enrolled